Evidence map›Paper›PMID 32925107›Full record

ArticleJournal of Parkinson's disease2020

The Effect of the COVID-19 Pandemic on People with Parkinson's Disease.

Ethan G Brown, Lana M Chahine, Samuel M Goldman, Monica Korell, Emerald Mann, Daniel R Kinel, Vanessa Arnedo, Kenneth L Marek, Caroline M Tanner

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Parkinson's disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 9 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 9 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Parkinson's disease and COVID-19: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. COVID-19 and Parkinson's Disease: What Do We Know So Far?Journal of Parkinson's disease · 2021
    Pooled it
  9. Pooled it
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ethan G BrownDepartment of Neurology, Weill Institute for the Neurosciences, University of California San Francisco, & San Francisco VA Health Care System, San Francisco, CA, USA.
Lana M ChahineDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Samuel M GoldmanDepartment of Occupational and Environmental Medicine, University of California San Francisco, & San Francisco VA Health Care System, San Francisco, CA, USA.
Monica KorellDepartment of Neurology, Weill Institute for the Neurosciences, University of California San Francisco, & San Francisco VA Health Care System, San Francisco, CA, USA.
Emerald MannDepartment of Neurology, Weill Institute for the Neurosciences, University of California San Francisco, & San Francisco VA Health Care System, San Francisco, CA, USA.
Daniel R KinelUniversity of Rochester, Rochester, NY, USA.
Vanessa ArnedoMichael J. Fox Foundation, New York, NY, USA.
Kenneth L MarekThe Institute for Neurodegenerative Disorders, New Haven, CT, USA.
Caroline M TannerDepartment of Neurology, Weill Institute for the Neurosciences, University of California San Francisco, & San Francisco VA Health Care System, San Francisco, CA, USA.
University of California, San Francisco · USInstitute for Neurodegenerative Disorders · USMichael J. Fox Foundation · USUniversity of Pittsburgh · USUniversity of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of the COVID-19 pandemic on people with Parkinson's disease (PD) is poorly understood.

objectiveTo rapidly identify areas of need and improve care in people with PD during the COVID-19 pandemic, we deployed a survey to assess COVID-19 symptoms and the pandemic's effect among those with and without COVID-19.

methodsPeople with and without PD participating in the online study Fox Insight (FI) were invited to complete a survey between April 23 and May 23, 2020. Among people reporting COVID-19 diagnoses, we compared symptoms and outcomes in people with and without PD. Among people not reporting COVID-19, we assessed access to healthcare and services and PD symptoms.

results7,209/9,762 active FI users responded (approximately 74% response rate), 5,429 people with PD and 1,452 without PD. COVID-19 diagnoses were reported by 51 people with and 26 without PD. Complications were more frequent in people with longer PD duration. People with PD and COVID-19 experienced new or worsening motor (63%) and nonmotor (75%) symptoms. People with PD not diagnosed with COVID-19 reported disrupted medical care (64%), exercise (21%), and social activities (57%), and worsened motor (43%) and non-motor (52%) symptoms. Disruptions were more common for those living alone, with lower income and non-White race.

conclusionsThe COVID-19 pandemic is associated with wide-ranging effects on people with PD, and certain groups may be at particular risk. FI provides a rapid, patient-centered means to assess these effects and identify needs that can be used to improve the health of people with PD.

Indexed as

AdultAgedAged, 80 and overCoronavirus InfectionsCOVID-19Cross-Sectional StudiesFemaleHealth Services AccessibilityHumansMaleMiddle AgedPandemicsParkinson DiseasePneumonia, ViralSurveys and QuestionnairesYoung AdultCOVID-19health care accessParkinson’s diseasesocial isolationtelemedicine

Identifiers

PMID32925107
PMCPMC7683050
OpenAlexW3086892979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.